
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1745-1770
Open Access | Times Cited: 1454
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1745-1770
Open Access | Times Cited: 1454
Showing 1-25 of 1454 citing articles:
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Zhenling Liu, Huanhuan Chen, Lili Zheng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 505
Zhenling Liu, Huanhuan Chen, Lili Zheng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 505
The role of microenvironment in tumor angiogenesis
Xianjie Jiang, Jie Wang, Xiangying Deng, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 501
Xianjie Jiang, Jie Wang, Xiangying Deng, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 501
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
Won Suk Lee, Hannah Yang, Hong Jae Chon, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1475-1485
Open Access | Times Cited: 469
Won Suk Lee, Hannah Yang, Hong Jae Chon, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1475-1485
Open Access | Times Cited: 469
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 455
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 455
NF-κB: At the Borders of Autoimmunity and Inflammation
Laura Barnabei, Emmanuel Laplantine, William Mbongo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 402
Laura Barnabei, Emmanuel Laplantine, William Mbongo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 402
Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role
Xinrong Wang, Alfredo Maria Bove, Giuseppe Simone, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 304
Xinrong Wang, Alfredo Maria Bove, Giuseppe Simone, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 304
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe, Malek Kreidieh, Hiba El Hajj, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 301
Yolla Haibe, Malek Kreidieh, Hiba El Hajj, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 301
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 250
Ewa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 250
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 215
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 215
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5840-5840
Open Access | Times Cited: 212
Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5840-5840
Open Access | Times Cited: 212
Cancer associated-fibroblast-derived exosomes in cancer progression
Chao Li, Adilson Fonseca Teixeira, Hong‐Jian Zhu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 212
Chao Li, Adilson Fonseca Teixeira, Hong‐Jian Zhu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 212
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours
Avishai Gavish, Michael Tyler, Alissa C. Greenwald, et al.
Nature (2023) Vol. 618, Iss. 7965, pp. 598-606
Closed Access | Times Cited: 211
Avishai Gavish, Michael Tyler, Alissa C. Greenwald, et al.
Nature (2023) Vol. 618, Iss. 7965, pp. 598-606
Closed Access | Times Cited: 211
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Cancer Letters (2021) Vol. 509, pp. 63-80
Closed Access | Times Cited: 196
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Cancer Letters (2021) Vol. 509, pp. 63-80
Closed Access | Times Cited: 196
Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment
Zijie Xu, Yi Chen, Ling Ma, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3133-3154
Open Access | Times Cited: 195
Zijie Xu, Yi Chen, Ling Ma, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3133-3154
Open Access | Times Cited: 195
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
Xuemei Yao, Wei Li, De Fang, et al.
Advanced Science (2021) Vol. 8, Iss. 22
Open Access | Times Cited: 181
Xuemei Yao, Wei Li, De Fang, et al.
Advanced Science (2021) Vol. 8, Iss. 22
Open Access | Times Cited: 181
Gene Therapy in Cancer Treatment: Why Go Nano?
Catarina Roma‐Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 177
Catarina Roma‐Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 177
The plasticity of mRNA translation during cancer progression and therapy resistance
Lucilla Fabbri, Alina Chakraborty, Caroline Robert, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 558-577
Closed Access | Times Cited: 177
Lucilla Fabbri, Alina Chakraborty, Caroline Robert, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 558-577
Closed Access | Times Cited: 177
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 176
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 176
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 173
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 173
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
Raefa Abou Khouzam, Klaudia Brodaczewska, Aleksandra Filipiak-Duliban, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 151
Raefa Abou Khouzam, Klaudia Brodaczewska, Aleksandra Filipiak-Duliban, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 151
Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective
Abdellah Akil, Ana K. Gutiérrez-García, Rachael Guenter, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 138
Abdellah Akil, Ana K. Gutiérrez-García, Rachael Guenter, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 138
New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease
Brian H. Annex, John P. Cooke
Circulation Research (2021) Vol. 128, Iss. 12, pp. 1944-1957
Open Access | Times Cited: 133
Brian H. Annex, John P. Cooke
Circulation Research (2021) Vol. 128, Iss. 12, pp. 1944-1957
Open Access | Times Cited: 133